NeuroBo signs license deal with Dong-A ST to develop two drug candidates

NeuroBo signs license deal with Dong-A ST to develop two drug candidates

Submitted by admin on September 16, 2022 - 10:16am
Source: 
Pharmaceutical Business Review
News Tags: 
NeuroBio
Dong-A ST
drug development
DA-1241
DA-1726
cardiometabolic diseases
Headline: 
NeuroBo signs license deal with Dong-A ST to develop two drug candidates
snippet: 

NeuroBo Pharmaceuticals has signed a conditional exclusive license agreement with Dong-A ST for the development and commercialisation of the latter’s cardio-metabolic therapies, DA-1241 and DA-1726.

Do Not Allow Advertisers to Use My Personal information